WebGazyvaro (obinutuzumab) An overview of Gazyvaro and why it is authorised in the EU What is Gazyvaro and what is it used for? Gazyvaro is a cancer medicine used to treat adults with: • previously untreated chronic lymphocytic leukaemia (CLL). CLL is a cancer of B-lymphocytes, a type of white blood cell. WebMay 13, 2024 · Gazyvaro 1,000 mg concentrate for solution for infusion Active Ingredient: obinutuzumab Company: Roche Products Limited See contact details ATC code: …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
WebAug 30, 2024 · The GAZAI (GAZyvaro and response Adapted Involved-site Radiotherapy) trial aims to prove the efficacy of LDRT in combination with a novel anti-CD20 therapy. Methods/design: The GAZAI trial is a non-randomized, open, non-controlled, German, multi-center phase II trial that includes patients with early-stage (I and II) nodular FL (grades 1 … WebOverview. On 10 October 2012, orphan designation (EU/3/12/1054) was granted by the European Commission to Roche Registration Limited, United Kingdom, for obinutuzumab for the treatment of chronic lymphocytic leukaemia. Obinutuzumab for treatment of chronic lymphocytic leukaemia has been authorised in the EU as Gazyvaro since 23 July 2014. la quinta hotels jackson tn
Fachinformation (Zusammenfassung der Merkmale des …
WebJun 1, 2024 · This is a phase 2 multicenter national interventional pharmacological study aimed at determining the efficacy of a fixed duration treatment with ibrutinib and obinutuzumab in terms of uMRD in the BM at the end of treatment (+30 Days follow-up). Treatment with ibrutinib and obinutuzumab will be administered according to the … WebFood and Drug Administration WebGazyvaro kann bei erwachsenen Patienten zur Behandlung von zwei verschiedenen Krebsarten angewendet werden. Chronische lymphatische Leukämie (auch „CLL“ … la quinta in bentonville arkansas